Go beyond raw coverage. Score your pipeline on age risk, stage distribution, and slip exposure to see what the number is really worth.
Pipeline health is not just about total value. A pipeline number in isolation tells you almost nothing useful — what matters is coverage ratio, stage distribution, deal age, and the quality of individual opportunities. A $5M pipeline can be extremely healthy or completely hollow depending on these factors.
Coverage ratio — total pipeline divided by quota — is the first number to check. Most organizations target 3x–4x coverage for quarterly forecasting. Below 2.5x is a red flag with limited room to absorb deal slippage. Above 6x often signals pipeline inflation: deals that won't close kept alive to make the forecast look better than it is.
Deal age is one of the most under-monitored risk signals. A deal that has been sitting in "Proposal" for 90 days when your average is 21 days is almost certainly stalled or lost — it's just taking up forecast bandwidth. Age-based risk scoring forces reps and managers to have honest conversations about which deals are real.
Stage distribution reveals the structural health of the pipeline. A pipeline heavy in early stages (discovery/qualification) with nothing in late stages signals a conversion or velocity problem. A pipeline heavy in late stages with nothing early signals future pipeline drought — you'll close this quarter but miss next quarter.
Slip rate — the percentage of deals that don't close in the quarter they're committed for — averages 20–35% across B2B companies. Understanding your slip rate changes how you calculate required coverage. If your slip rate is 25% and you need $1M in closed revenue, your pipeline at quarter start needs to be $1M ÷ (1 − 0.25) = $1.33M in qualified pipeline, not $1M.
Run this scorer weekly in your pipeline review call. Deals flagged as at-risk by age should be reviewed with the rep for either a clear next step with a committed date or removal from the forecast. Keeping stale deals alive inflates confidence, distorts forecasts, and ultimately causes bigger misses at quarter end.
3x–4x is the standard benchmark for quarterly pipeline coverage. For companies with shorter sales cycles (<30 days), 2x may be sufficient. For enterprise deals with 6+ month cycles and high slip rates, 5x–6x is common. The key insight: your coverage requirement = 1 ÷ (1 - slip_rate).
Divide total qualified pipeline value by your revenue target for the period. If you have $3M in active pipeline and a $1M quarterly target, your coverage ratio is 3x. Only count qualified opportunities — not anything in a discovery or early-interest stage.
Deal slippage occurs when a deal committed to close in a given period doesn't close and moves to a future period. Average B2B slippage is 20–35% per quarter. Slippage is not necessarily a sign of a bad deal — it often reflects optimistic timing assumptions or external buyer delays. But chronic slippage signals a forecasting accuracy problem.
Three primary signals: (1) Deal age — the deal has been in the current stage significantly longer than your average stage duration. (2) No recent activity — no emails, calls, or meetings logged in 2+ weeks on a deal in a late stage. (3) Missing key contacts — no engagement from the economic buyer or champion. Run a pipeline review against all three criteria weekly.
Discuss this in #pipeline-review with 194+ revenue operators in the community.